Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Autoimmune skin diseases result from genetic and environmental factors disrupting immune checkpoints.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Testing for various autoantibodies in Indian children with lupus can help predict disease symptoms and risks.

Autoinflammatory skin diseases are complex, increasingly common, and significantly affect quality of life.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Belatacept may be a promising treatment for alopecia areata.

Male-to-female skin grafts in mice are rejected due to sex-linked antigens.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Machine learning can help find new ways to treat alopecia areata.

Some people with chronic hair loss may have thyroid autoimmunity.